An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels.
Metabolic syndrome has been defined as the presence of abdominal obesity combined with 2 of the following factors: hypertension, dyslipidemia, and impaired glucose tolerance, or diabetes mellitus. Magnesium is an essential cofactor for more than 300 enzymes involved in carbohydrate and lipid metabolism. In this study, we enrolled 117 consecutive overweight and obese patients and we measured serum magnesium levels together with fasting serum glucose, high-density lipoprotein cholesterol, and triacylglycerols. A strong inverse relationship between magnesium levels in serum and the presence of metabolic syndrome was noticed. Moreover, magnesium levels decreased as the number of components of metabolic syndrome increased. Also, there is an inverse relationship between serum magnesium levels and high-sensitivity C-reactive protein. We concluded that decreased levels of serum magnesium are associated with increased risk for metabolic syndrome, perhaps by a low-grade inflammation process.
Evangelopoulos
Angelos A
AA
Department of Microbiology, Polykliniki General Hospital, 10552 Athens, Greece.
Vallianou
Natalia G
NG
Panagiotakos
Demosthenes B
DB
Georgiou
Aikaterini
A
Zacharias
Georgios A
GA
Alevra
Andri N
AN
Zalokosta
Georgia J
GJ
Vogiatzakis
Evangelos D
ED
Avgerinos
Peter C
PC
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008274:Magnesium / Q000097:blood*; D008275:Magnesium Deficiency / Q000150:complications; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000453:epidemiology; D009765:Obesity / Q000097:blood* / Q000453:epidemiology; D012307:Risk Factors
D001786:Blood Glucose; D008055:Lipids; D002097:C-Reactive Protein; D008274:Magnesium